Dolby (NYSE: DLB) logs CEO Marc Whitten with zero trades

Rhea-AI Filing Summary

Dolby Laboratories, Inc. (DLB) filed an initial statement of beneficial ownership (Form 3) for Marc Whitten. He is listed as a director and as an officer

Key Figures

Buy transactions reported: 0 Sell transactions reported: 0 Derivative transactions reported: 0

3 metrics

Buy transactions reported 0 Transaction summary buyCount for Marc Whitten

Sell transactions reported 0 Transaction summary sellCount for Marc Whitten

Derivative transactions reported 0 Transaction summary derivativeTransactionCount for Marc Whitten

Key Terms

Form 3, reporting person, beneficial ownership

3 terms

Form 3 regulatory

"filed an initial statement of beneficial ownership (Form 3) for Marc Whitten"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"The reporting person is Marc Whitten"

beneficial ownership financial

"filed an initial statement of beneficial ownership (Form 3)"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

What does this Form 3 filing mean for Dolby Laboratories, Inc. (DLB)?

It records Marc Whitten as a reporting person for Dolby Laboratories, Inc., identifying him as a director and President and CEO. The filing establishes his status under SEC ownership reporting rules but does not disclose any transactions or holdings.

Who is the reporting person in this Dolby (DLB) Form 3?

The reporting person is Marc Whitten. He is identified as both a director and an officer of Dolby Laboratories, Inc., with the officer title “President and CEO.”

Does Marc Whitten report any share transactions in this DLB Form 3?

No. The Form 3 lists no transactions. Buy, sell, acquisition, disposition, and derivative transaction counts are all zero in the transaction summary.

Are any derivative securities reported for Marc Whitten in DLB?

No. The derivativeSummary is empty, and the transaction summary shows a derivative transaction count of zero, indicating no derivative positions reported in this Form 3.

Is this Dolby (DLB) Form 3 filed under a Rule 10b5-1 trading plan?

No. The filing’s aff_10b5_one field is null, and there are no transactions or footnote disclosures indicating activity under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 08/28/2026 - 06:02 PM Accepted by SEC EDGAR 08/28/2026 - 06:01 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Whitten Marc

(Last) (First) (Middle)

C/O DOLBY LABORATORIES, INC.

1275 MARKET STREET

(Street)

SAN FRANCISCO CALIFORNIA 94103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/27/2026

3. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Dan Rodriguez as Attorney-in-Fact for Marc Whitten	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)